EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review-Reference-Cited by-同舟云学术

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

Published:2017-06-30 Issue:5-6 Volume:8 Page:589-599
ISSN:1947-6027
Container-title:Genes & Cancer
language:en
Short-container-title:Genes Cancer

Author:

Mehner Christine¹,Oberg Ann L.²,Goergen Krista M.²,Kalli Kimberly R.³,Maurer Matthew J.²,Nassar Aziza⁴,Goode Ellen L.⁵,Keeney Gary L.⁶,Jatoi Aminah³,Radisky Derek C.¹,Radisky Evette S.¹

Affiliation:

1. Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA

2. Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA

3. Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA

4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA

5. Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA

6. Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA

Publisher

Impact Journals, LLC

Subject

Cancer Research,Genetics

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ETS1 drives EGF-induced glycolytic shift and metastasis of epithelial ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer;Pathology - Research and Practice;2024-06

3. Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)‐induced phenotypes for platinum sensitivity and long‐term survival in ovarian cancer—A study from the OVCAD consortium;International Journal of Cancer;2024-05-06

4. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway;Cancer Management and Research;2024-05

5. EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma;Cancer Biomarkers;2024-04-15